Group 1 - The company has changed its English name from "Genor Biopharma Holdings Limited" to "Edding Genor Group Holdings Limited" and its Chinese name from "嘉和生物药业(开曼)控股有限公司" to "亿腾嘉和医药集团有限公司," effective from December 30, 2025 [1] - The change in company name has been approved by shareholders at a special meeting and registered with the Cayman Islands Registrar of Companies [1] - The Hong Kong Companies Registry has confirmed the new names have been registered under the Companies Ordinance [1] Group 2 - The company's stock trading name on the Hong Kong Stock Exchange will change from "GENOR" to "EDDING GENOR," and the Chinese stock name will change from "嘉和生物" to "亿腾嘉和," effective from February 6, 2026 [2] - The company's stock code on the Hong Kong Stock Exchange will remain "6998" [2] - The name changes aim to better reflect the expanded business of the group following the completion of a merger and the relationship with the controlling shareholder [2]
嘉和生物拟更改股份简称为“亿腾嘉和”